Interferon-gamma administration to patients after major surgery influences cellular immunity without pro-inflammatory response

European Journal of Clinical Investigation

Volumn 32, Issue 10, 2002, Pages 787-789

  De Metz, J ^a   Sauerwein, H P ^a   Gouma, D J ^a   Out, T A ^a   Reijneke, R M R ^a   Hack, C E ^a   Romijn, J A ^b   Ten Berge, I J M ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Leiden University Medical Center ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ELASTASE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; IMMUKINE; INTERLEUKIN 10; INTERLEUKIN 6; LACTOFERRIN; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME BLOOD LEVEL; GRANULOCYTE; HUMAN; INFLAMMATION; LETTER; MONOCYTE; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADJUVANTS, IMMUNOLOGIC; ADULT; CASE-CONTROL STUDIES; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERFERON-GAMMA, RECOMBINANT; POSTOPERATIVE COMPLICATIONS;

EID: 0036431458     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01073.x     Document Type: Letter

References (13)

1. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC Jr. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988;123:1309-12.
2. Klava A, Windsor A, Boylston AW, Reynolds JV, Ramsden CW, Guillou PJ. Monocyte activation after open and laparoscopic surgery. Br J Surg 1997;84:1152-56.
3. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990;77:204-7.
4. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996;131:1303-8.
5. Decker D, Schondorf M, Bidlingmaier F, Hirner A, von Ruecker AA. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up- regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996;119:316-25.
6. Kox WJ, Bone RC, Krausch D, Docke WD, Kox JN, Waver H et al. Interferon gamma-1b in the treatment of compensatory anti- inflammatory response syndrome. A new approach: Proof of principle. Arch Intern Med 1997;157:389-93.
7. Polk HC Jr., Cheadle WG, Livingston DH, Rodriguez JL, Starko KM, I Zu AE et al. A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992;163:191-6.
8. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997;66:101-95.
9. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
10. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 1990;161:982-7.
11. de Metz J, Hack CE, Romijn JA, Leu M, Out TA, ten Berge IJ et al. Interferon-γ in healthy subjects: selective modulation of inflammatory mediators. Eur J Clin Invest 2000;31:536-43.
12. de Metz J, Romijn JA, Gouma DJ, ten Berge IJ, Busch OR, Endert E et al. Interferon-gamma administration does not affect human thyroid hormone metabolism in the post surgical euthyroid sick syndrome. J Endocrinol Invest 2002;25:315-20.
13. Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Streive SN, Weigeit JA et al. Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Am J Surg 1994;129:1031-41.